Related Experiment Videos
Methysergide potentiates the hyperactivity produced by MDMA in rats
1Department of Basic and Clinical Research, Research Institute of Scripps Clinic, La Jolla, CA 92037.
Pharmacology, Biochemistry, and Behavior
|March 1, 1988
Summary
Blocking serotonin receptors amplified MDMA-induced hyperactivity in rats, suggesting serotonin
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- MDMA exhibits complex pharmacology, interacting with serotonin and dopamine systems.
- Serotonergic and sympathomimetic effects of MDMA contribute to its behavioral outcomes.
- Previous research indicates MDMA depletes brain serotonin.
Purpose of the Study:
- To investigate the role of serotonin receptors in MDMA-induced locomotor hyperactivity.
- To differentiate the mechanisms underlying MDMA and amphetamine locomotor effects.
Main Methods:
- Rats were administered methysergide (a serotonin receptor blocker) alone or with MDMA or amphetamine.
- Locomotor activity was measured using photocell cages over 120 minutes.
- Dose-response effects of methysergide were examined.
Main Results:
- Methysergide alone did not affect locomotor activity.
- Methysergide significantly potentiated MDMA-induced hyperactivity.
- Methysergide did not potentiate amphetamine-induced hyperactivity.
Conclusions:
- MDMA's intrinsic serotonergic activity may mitigate its sympathomimetic effects.
- Serotonin receptor blockade enhances the locomotor stimulant effects of MDMA.
- This suggests a complex interplay between serotonergic and sympathomimetic pathways in MDMA's action.